Clinical Trials
What You Need to Know
Imalia will launch a Phase 2/3 study in 2025.
Trial Locations: USA, England, France, India, Quatar
- Enrollment Start Date: Q4 2025
- Eligibility Criteria: patients above 12
- Trial Goals:
- Safety and tolerability.
- VOC crisis reduction.
- Patient outcomes and quality of life improvements.
Stay Informed
Sign up for updates on trial progress, publications, and results as we continue to advance our research.